The OPAX opacity monitoring sensor from EMX Industries verifies quality of packaging in real time.
The OPAX opacity monitoring sensor from EMX Industries is an automated, light-sensing system that screens packages for acceptable quality in real time and helps control production equipment. The automated system inspects 100% of packages, compared to labor-intensive visual batch control, which relies on statistical sampling.
Control and verification of a light barrier in pharmaceutical packaging is crucial, because pharmaceuticals may be degraded by the amount of light (both visible and non-visible) that passes through them, shortening their shelf life. The OPAX opacity sensor verifies the opacity of packaged goods while outputting a signal to remove the defective unit from the line. The system can be used for various types of bottles and containers.
Source: EMX Industries
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.